Waleed H. Hassanein, President & CEO at TransMedics Group, Inc. (TMDX), sold 15,750 shares at $134.23 ($2.1M) on 2024-10-15, disclosed to the SEC on 2024-10-17.
Scheduled sale ($2.1M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.91 | 3,607 | $476K | 22.8% |
| 2 | $131.91 | 3,607 | $476K | 22.8% |
| 3 | $132.82 | 3,518 | $467K | 22.4% |
| 4 | $132.82 | 3,518 | $467K | 22.4% |
| 5 | $134.23 | 1,200 | $161K | 7.7% |
| 6 | $135.04 | 300 |
| $41K |
| 1.9% |
| Total | $132.55 avg | 15,750 | $2.1M | 100% |
| Filing → |
| TMDX | SELL | 2024-09-17 | $2.6M | — | Filing → |
| TMDX | SELL | 2024-08-23 | $7.8M | — | Filing → |
| TMDX | SELL | 2024-08-19 | $2.6M | — | Filing → |